| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2006 | WO2006084217A2 Rnai-mediated inhibition of ocular hypertension targets |
| 08/10/2006 | WO2006084200A2 Nitroxides for use in treating or preventing cardiovascular disease |
| 08/10/2006 | WO2006084199A2 Nitroxides for use in treating or preventing amyloid-related diseases |
| 08/10/2006 | WO2006084198A2 Nitroxides for use in treating or preventing immunological diseases |
| 08/10/2006 | WO2006084197A2 Nitroxides for use in treating or preventing neoplastic disease |
| 08/10/2006 | WO2006084176A2 Compounds and compositions as ppar modulators |
| 08/10/2006 | WO2006084153A2 Methods and materials with trans-clomiphene for the treatment of male infertility |
| 08/10/2006 | WO2006084116A2 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer |
| 08/10/2006 | WO2006084082A1 Compositions of unconjugated estrogens and methods for their use |
| 08/10/2006 | WO2006084073A2 Aqueous gel formulations containing 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 08/10/2006 | WO2006084056A2 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 08/10/2006 | WO2006084053A1 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| 08/10/2006 | WO2006084043A2 Novel chloride channel pore openers |
| 08/10/2006 | WO2006084041A2 Nitroxides for use in treating or preventing diabetes |
| 08/10/2006 | WO2006084031A1 Imines as ion channel modulators |
| 08/10/2006 | WO2006084030A2 Small-molecule hsp90 inhibitors |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083970A2 Tumor necrosis factor inhibitors |
| 08/10/2006 | WO2006083949A2 Sepsis prevention through adenosine receptor modulation |
| 08/10/2006 | WO2006083947A2 Compositions and methods for treating fibrotic disorders |
| 08/10/2006 | WO2006083945A2 Rnai-mediated inhibition of ocular targets |
| 08/10/2006 | WO2006083930A2 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 08/10/2006 | WO2006083924A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | WO2006083916A2 Novel adenosine a3 receptor modulators |
| 08/10/2006 | WO2006083908A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 08/10/2006 | WO2006083869A2 Tumor necrosis factor inhibitors |
| 08/10/2006 | WO2006083841A2 Therapeutic esters |
| 08/10/2006 | WO2006083840A1 Combination of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 08/10/2006 | WO2006083810A2 Polycarboxylated porphyrins and use thereof in treatment of metal toxicities |
| 08/10/2006 | WO2006083781A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083760A1 AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE |
| 08/10/2006 | WO2006083711A1 Tachykinin receptor antagonists |
| 08/10/2006 | WO2006083710A2 Use of 5-ht4 agonist for treating delayed gastric emptying which may be induced by a proton pump inhibitor |
| 08/10/2006 | WO2006083692A2 Methods of identifying modulators of bromodomains |
| 08/10/2006 | WO2006083687A1 Crystal salt of xanthine oxidase inhibitors |
| 08/10/2006 | WO2006083682A2 Polymorphic forms of a gabaa agonist |
| 08/10/2006 | WO2006083678A2 β-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083653A2 Systems and methods for delivery of peritoneal dialysis (pd) solutions |
| 08/10/2006 | WO2006083645A2 Formulations and dosing regimen for ppar-alpha modulators |
| 08/10/2006 | WO2006083628A2 Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species |
| 08/10/2006 | WO2006083622A2 Control of enterohemorrhagic e. coli in farm animal drinking water |
| 08/10/2006 | WO2006083618A1 NANDROLONE 17ß-CARBONATES |
| 08/10/2006 | WO2006083612A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083608A1 Process for producing polypeptide mixtures using hydrogenolysis |
| 08/10/2006 | WO2006083553A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 08/10/2006 | WO2006083538A1 Aminoalkylphenyl indolone derivatives |
| 08/10/2006 | WO2006083486A1 Amorphous tacrolimus and preparation thereof |
| 08/10/2006 | WO2006083477A2 Compounds for inflammation and immune-related uses |
| 08/10/2006 | WO2006083458A2 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006083440A2 Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| 08/10/2006 | WO2006083434A1 Use of arachidonic acid and its derivatives for increasing skeletal muscle mass |
| 08/10/2006 | WO2006083417A2 Processes of making sesquiterpenoid tashironin, its analogs and their uses |
| 08/10/2006 | WO2006083366A2 Preparation of ginkgolide and f-seco-ginkgolide lactols |
| 08/10/2006 | WO2006083328A2 Biologically active surfaces and methods of their use |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006083257A2 Drug delivery apparatus utilizing cantilever |
| 08/10/2006 | WO2006083214A1 Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor |
| 08/10/2006 | WO2006083204A1 Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor |
| 08/10/2006 | WO2006083051A1 G6pd enzyme inhibitor and method for treating obesity using the same |
| 08/10/2006 | WO2006083019A1 AMYLOID β PROTEIN AGGREGATION INHIBITOR, DIAGNOSTIC AGENT FOR ABNORMALITY OF AMYLOID β PROTEIN, AND DIAGNOSTIC KIT FOR ABNORMALITY OF AMYLOID β PROTEIN |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006083003A1 Novel benzamidine compound |
| 08/10/2006 | WO2006082978A1 Acylamide compound with action of enhancing secretion of adiponectin or inducing adiponectin |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082888A1 Percutaneous absorption preparation |
| 08/10/2006 | WO2006082872A1 1-(piperidin-4-yl)-1h-indole derivative |
| 08/10/2006 | WO2006082842A1 Hard capsule having improved solubility |
| 08/10/2006 | WO2006082834A1 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 08/10/2006 | WO2006082822A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 08/10/2006 | WO2006082821A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | WO2006082820A1 Therapeutic agent for herpes progenitalis |
| 08/10/2006 | WO2006082771A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component 1-aminocyclopropanecarboxylic acid or the like |
| 08/10/2006 | WO2006082743A1 Therapeutic agent |
| 08/10/2006 | WO2006082728A1 Transdermal absorption patch |
| 08/10/2006 | WO2006082707A1 Immune enhancer |
| 08/10/2006 | WO2006082647A1 Immunopotentiator |
| 08/10/2006 | WO2006082643A1 Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy |
| 08/10/2006 | WO2006082598A2 Novel crystalline forms of rizatriptan benzoate |
| 08/10/2006 | WO2006082511A1 Novel salt form of a dopamine agonist |
| 08/10/2006 | WO2006082500A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| 08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
| 08/10/2006 | WO2006082492A1 Azabicyclo derivatives as anti-inflammatory agents |
| 08/10/2006 | WO2006082490A1 Injectable formulations of benzimidazole compounds |
| 08/10/2006 | WO2006082456A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
| 08/10/2006 | WO2006082428A2 Combination therapies using hdac inhibitors |
| 08/10/2006 | WO2006082412A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | WO2006082409A2 Tricyclic cytoprotective compounds |
| 08/10/2006 | WO2006082404A1 Compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082401A1 Chemical compounds |
| 08/10/2006 | WO2006082400A1 Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| 08/10/2006 | WO2006082397A1 New uses of dinucleotide polyphosphate derivatives |
| 08/10/2006 | WO2006082392A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082371A1 Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082309A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |